Hypertension and anesthesia

Current Opinion in Anaesthesiology

Volumn 19, Issue 3, 2006, Pages 315-319

  Hanada, Satoshi ^a   Kawakami, Hiromasa ^a   Goto, Takahisa ^b   Morita, Shigeho ^a  

^a TEIKYO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b YOKOHAMA CITY UNIVERSITY   (Japan)

Author keywords

Anesthesia; Complication; Hypertension; Perioperative

Indexed keywords

ALPHA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; ANESTHETIC AGENT; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIHYPERTENSIVE AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CLONIDINE; DEXMEDETOMIDINE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; MIVAZEROL; NIFEDIPINE; THIAZIDE DIURETIC AGENT;

ANESTHESIA; BLOOD PRESSURE REGULATION; CARDIOVASCULAR RISK; CEREBROVASCULAR DISEASE; CLINICAL PROTOCOL; CLINICAL TRIAL; CORONARY ARTERY DISEASE; DISEASE SEVERITY; DRUG SAFETY; DRUG USE; ELECTIVE SURGERY; GOAL ATTAINMENT; HEART FAILURE; HEART HEMODYNAMICS; HEART INFARCTION; HEART MUSCLE ISCHEMIA; HUMAN; HYPERTENSION; HYPOTENSION; ISCHEMIC HEART DISEASE; KIDNEY DISEASE; LIFESTYLE; PERIOPERATIVE PERIOD; PREOPERATIVE PERIOD; PRIORITY JOURNAL; REVIEW; STROKE; SYSTOLIC HYPERTENSION; TARGET ORGAN;

ANESTHESIA; HEART DISEASES; HUMANS; HYPERTENSION; INTRAOPERATIVE CARE; MIDDLE AGED;

EID: 33744973280     PISSN: 09527907     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.aco.0000192811.56161.23     Document Type: Review

References (40)

1. Guilbert JJ. The World Health Report 2002: reducing risks, promoting healthy life. Educ Health (Abingdon) 2003; 16:230.
2. Lewington S, Clarke R, Qizilbash N, et al. Prospective Studies Collaboration. Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies. Lancet 2002; 360:1903-1913.
3. Chobanian AV, Bakris GL, Black HR, et al. National Heart, Lung, and Blood Institute Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. National High Blood Pressure Education Program Coordinating Committee. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA 2003; 289:2560-2572.
4. American Diabetes Association. Treatment of hypertension in adults with diabetes. Diabetes Care 2003; 26:S80-S82 (PR).
5. National Kidney Foundation Guideline. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Kidney Disease Outcome Quality Initiative. Am J Kidney Dis 2002; 39:S1-S246 (PR).
6. The ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group. Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). JAMA 2002; 288:2981-2997.
7. Franklin SS, Jacobs MJ, Wong ND, et al. Predominance of isolated systolic hypertension among middle-aged and elderly US hypertensives: analysis based on National Health and Nutrition Examination Survey (NHANES) III. Hypertension 2001; 37:869-874.
8. Staessen JA, Gasowski J, Wang JG, et al. Risks of untreated and treated isolated systolic hypertension in the elderly: meta-analysis of outcome trials. Lancet 2000; 355:865-872.
9. Kannel WB. Elevated systolic blood pressure as a cardiovascular risk factor. Am J Cardiol 2000; 85:251-255 (Review).
10. Gasowski J, Fagard RH, Staessen JA, et al. INDANA Project Collaborators. Pulsatile blood pressure component as predictor of mortality in hypertension: a meta-analysis of clinical trial control groups. J Hypertens 2002; 20:145-151.
11. Blacher J, Staessen JA, Girerd X, et al. Pulse pressure not mean pressure determines cardiovascular risk in older hypertensive patients. Arch Intern Med 2000; 160:1085-1089.
12. Kaplan NM. New issues in the treatment of isolated systolic hypertension. Circulation 2000; 102:1079-1081.
13. Prys-Roberts C, Meloche R, Foex P. Studies of anaesthesia in relation to hypertension I: cardiovascular responses on treated and untreated patients. Br J Anaesth 1971; 43:122-137.
14. Prys-Roberts C, Groere LT, Meloche R, Foex P. Studies of anaesthesia in relation to hypertension II: haemodynamic consequences of induction and endotracheal intubation. Br J Anaesth 1971; 43:531-547.
15. Prys-Roberts C, Foex P, Greene LT, Waterhouse TD. Studies of anaesthesia in relation to hypertension. IV. The effects of artificial ventilation on the circulation and pulmonary gas exchanges. Br J Anaesth 1972; 44:335-349.
16. Goldman L, Caldera DL, Nussbaum SR, et al. Multifactorial index of cardiac risk in noncardiac surgical procedures. N Engl J Med 1977; 297:845-850.
17. Goldman L, Caldera DL, Southwick FS, et al. Cardiac risk factors and complications in noncardiac surgery. Medicine (Baltimore) 1978; 57:357-370.
18. Goldman L, Caldera DL. Risks of general anesthesia and elective operation in the hypertensive patient. Anesthesiology 1979; 50:285-292.
19. Howell SJ, Sear JW, Foex P. Hypertension, hypertensive heart disease and perioperative cardiac risk. Br J Anaesth 2004; 92:570-583 (Review).
20. Howell SJ, Sear YM, Yeates D, et al. Risk factors for cardiovascular death after elective surgery under general anaesthesia. Br J Anaesth 1998; 80:14-19.
21. Howell SJ, Sear JW, Sear YM, et al. Risk factors for cardiovascular death within 30 days after anaesthesia and urgent or emergency surgery: a nested case-control study. Br J Anaesth 1999; 82:679-684.
22. Eagle KA, Berger PB, Calkins H, et al. ACC/AHA Guideline Update for Perioperative Cardiovascular Evaluation for Noncardiac Surgery - Executive Summary. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to update the 1996 guidelines on Perioperative Cardiovascular Evaluation for Noncardiac Surgery). Anesth Analg 2002; 94:1052-1064.
23. Spahn DR, Priebe HJ. Editorial II: Preoperative hypertension: remain wary? 'Yes' - cancel surgery? 'No'. Br J Anaesth 2004; 92:461-464.
24. Weksler N, Klein M, Szendro G, et al. The dilemma of immediate preoperative hypertension: to treat and operate, or to postpone surgery? J Clin Anesth 2003; 15:179-183.
25. Lee TH, Marcantonio ER, Mangione CM, et al. Derivation and prospective validation of a simple index for prediction of cardiac risk of major noncardiac surgery. Circulation 1999; 100:1043-1049.
26. Lawes CM, Rodgers A, Bennett DA, et al. Asia Pacific Cohort Studies Collaboration. Blood pressure and cardiovascular disease in the Asia Pacific region. J Hypertens 2003; 21:707-716.
27. Charlson ME, MacKenzie CR, Gold JP, et al. Intraoperative blood pressure: what patterns identify patients at risk for postoperative complications? Ann Surg 1990; 212:567-580.
28. Reich DL, Bennett-Guerrero E, Bodian CA, et al. Intraoperative tachycardia and hypertension are independently associated with adverse outcome in noncardiac surgery of long duration. Anesth Analg 2002; 95:273-277.
29. Poldermans D, Boersma E, Bax JJ, et al. The effect of bisoprolol on perioperative mortality and myocardial infarction in high-risk patients undergoing vascular surgery. Dutch Echocardiographic Cardiac Risk Evaluation Applying Stress Echocardiography Study Group. N Engl J Med 1999; 341:1789-1794.
30. Mangano DT, Layug EL, Wallace A, Tateo I. Effect of atenolol on mortality and cardiovascular morbidity after noncardiac surgery. Multicenter Study of Perioperative Ischemia Research Group. N Engl J Med 1996; 335:1713-1720.
31. Howell SJ, Sear JW, Foex P. Peri-operative beta-blockade: a useful treatment that should be greeted with cautious enthusiasm. Br J Anaesth 2001; 86:161-164 (Review).
32. Lindenauer PK, Pekow P, Wang K, et al. Perioperative beta-blocker therapy and mortality after major noncardiac surgery. N Engl J Med 2005; 353:349-361. This article describes an observational study that analyses β-blocker therapy in a large number of varied patients.
33. Devereaux PJ, Yusuf S, Yang H, et al. Are the recommendations to use perioperative beta-blocker therapy in patients undergoing noncardiac surgery based on reliable evidence? CMAJ 2004; 171:245-247.
34. Wijeysundera DN, Naik JS, Beattie WS. Alpha-2 adrenergic agonists to prevent perioperative cardiovascular complications: a meta-analysis. Am J Med 2003; 114:742-752.
35. Brabant SM, Bertrand M, Eyraud D, et al. The hemodynamic effects of anesthetic induction in vascular surgical patients chronically treated with angiotensin II receptor antagonists. Anesth Analg 1999; 89:1388-1392.
36. Behnia R, Molteni A, Igic R. Angiotensin-converting enzyme inhibitors: mechanisms of action and implications in anesthesia practice. Curr Pharm Des 2003; 9:763-776 (Review).
37. Coriat P, Richer C, Douraki T, et al. Influence of chronic angiotensin-converting enzyme inhibition on anesthetic induction. Anesthesiology 1994; 81:299-307.
38. Bertrand M, Godet G, Meersschaert K, et al. Should the angiotensin II antagonists be discontinued before surgery? Anesth Analg 2001; 92:26-30.
39. Brabant SM, Eyraud D, Bertrand M, Coriat P. Refractory hypotension after induction of anesthesia in a patient chronically treated with angiotensin receptor antagonists. Anesth Analg 1999; 89:887-888.
40. Comfere T, Sprung J, Kumar MM, et al. Angiotensin system inhibitors in a general surgical population. Anesth Analg 2005; 100:636-644. This retrospective study analyzes the relationship between the timing of withholding of chronic ACEI/ARA therapy and hypotension after the induction of general anesthesia.